Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.22.2.2
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - $ / shares
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common Stock, par value $ 0.001   $ 0.001
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 23,339,777 21,954,883  
Warrants to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 4,030,487 4,535,804  
Options to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 811,924 836,732  
Unvested Restricted Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 18,446,254 16,372,752  
Unvested Restricted Stock Units [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 51,111 209,595